So-Young International Inc.

NASDAQ:SY

Medical - Healthcare Information Services

Healthcare
$1.83 -5.83%

-$0.09 today

Market cap
$239.36M
Beta
1.98
P/E (TTM)
-5.0
EPS (TTM)
-$1.95
52W Low $1.00High $6.28

Volume 0.46M

Average 0.63M

SY Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

So-Young International Inc.NASDAQ: SY

Operating Margin · Q1 FY2026 · quarter ended Mar 2026

Operating margin widens to -13.4%

Operating margin was -13.4% in Q1 FY2026, up 1.2 pp from a year earlier. On a trailing-twelve-month basis it was -16.9%, up 26.7 pp year over year. Over 3 fiscal years it narrowed by 9.3 pp.

Context

  • Operating margin widened in 2 of the last 3 fiscal years.

What to watch

Whether operating margin reaches the consensus estimate from 2 analysts of -10.0% for the fiscal year ending Dec 2026, up from -17.5% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-13.4%+9.0 pp QoQ
Last fiscal yearDec 2025
-17.5%+25.1 pp YoY
LTMMar 2026
-16.9%+26.7 pp YoY
Operating Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+1.2 pp-4.0 pp-5.2 pp
1 year+25.1 pp+7.5 pp-17.6 pp
3 years-9.3 pp+22.5 pp+31.9 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Operating Margin history

Percent of revenue · from the income statement

Latest · FY2025
-17.5%
Year-over-year change
+25.1pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Operating Margin vs competitors

How SY compares with its peers on the latest reported figures

  • SY's LTM Mar 2026 operating margin of -16.9% is the 2nd highest of the 9 companies compared; the peer median is -85.9%.
  • Its year-over-year change of +26.7 pp is the 2nd highest of 8, against a peer median of -2.5 pp.
  • Over three fiscal years its change of -9.3 pp compares with a peer median of -3.0 pp.
SY Competitors Peer median
Operating Margin for SY and competitors
Company Period LTM level YoY 3-year change
VREXVarex Imaging CorporationLTM Apr 2026-3.7% -10.1 pp-13.6 pp
SYSo-Young International Inc.LTM Mar 2026-16.9% +26.7 pp-9.3 pp
SNDASonida Senior Living, Inc.LTM Mar 2026-20.5% -16.1 pp-3.0 pp
LXRXLexicon Pharmaceuticals, Inc.LTM Mar 2026-34.8% +533.8 pp+72391.0 pp
SLPSimulations Plus, Inc.LTM Feb 2026-83.5% -88.0 pp-117.0 pp
SOPHSOPHiA GENETICS S.A.LTM Mar 2026-88.4% +6.7 pp+92.9 pp
LABStandard BioTools Inc.LTM Mar 2026-91.0% -2.5 pp+9.3 pp
ADCTADC Therapeutics S.A.LTM Mar 2026-149.6% +15.9 pp-74.5 pp
OMEROmeros CorporationLTM Mar 2026-1063.9% ——
CGEMCullinan Therapeutics, Inc.FY2025— ——
NMRANeumora Therapeutics, Inc. Common StockFY2025— ——
Peer median (excluding SY) -85.9%-2.5 pp-3.0 pp

Competitors are the stored peer set for SY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CNY
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.69B1.26B1.5B1.47B1.48B
Cost of Revenue327.89M393.29M544.34M567.59M774.04M
Gross Profit1.36B864.58M953.69M899.11M707.86M
Gross Margin80.6%68.7%63.7%61.3%47.8%
Research & Development286.57M235.09M203.52M165.03M133.31M
Selling, General & Admin1.04B732.3M811.22M818.57M833.76M
Operating Expenses1.4B967.39M1.01B1.52B967.07M
Depreciation & Amortization30.08M47.09M46.09M46.09M57.21M
EBITDA63.39M(39.99M)53.96M(38.39M)(182.19M)
EBITDA Margin3.7%-3.2%3.6%-2.6%-12.3%
Operating Income(32.57M)(102.81M)(61.05M)(624.49M)(259.21M)
Operating Margin-1.9%-8.2%-4.1%-42.6%-17.5%
Interest Income19.33M28.88M48.84M46.51M24.6M
Interest Expense00000
Other Income / Expenses16.17M15.73M68.92M36.41M19.8M
Income Before Tax(16.41M)(87.07M)7.87M(588.09M)(239.4M)
Pre-Tax Margin-1.0%-6.9%0.5%-40.1%-16.2%
Income Tax Expense21.23M(20.97M)(18.08M)(905K)(774.31K)
Net Income(8.37M)(65.55M)21.28M(589.53M)(235.7M)
Net Margin-0.5%-5.2%1.4%-40.2%-15.9%
EPS (Basic)(0.06)(0.48)0.16(4.40)(1.78)
EPS (Diluted)(0.06)(0.48)0.16(4.39)(1.78)
Weighted Avg Shares138.04M138.04M133.19M134.09M131.59M
Weighted Avg Shares (Diluted)138.04M138.04M131.91M134.16M131.59M

So-Young International Inc.

NASDAQ:SY

Intrinsic Alpha fair value

Locked

Current Price

$1.83

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.